{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:08:17Z","timestamp":1788480497826,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NMRPG8K0101"],"award-info":[{"award-number":["NMRPG8K0101"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.biopha.2022.112745","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T11:37:25Z","timestamp":1645443445000},"page":"112745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Combined levosimendan and Sacubitril\/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat"],"prefix":"10.1016","volume":"148","author":[{"given":"Pei-Hsun","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Tan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Y.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hon-Kan","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2022.112745_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure","volume":"113","author":"Roger","year":"2013","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.biopha.2022.112745_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrcardio.2016.119","article-title":"Heart failure: improvement of LVEF in patients with HF is linked to better prognosis","volume":"13","author":"Huynh","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.biopha.2022.112745_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ejhf.872","article-title":"Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"19","author":"Harjola","year":"2017","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.biopha.2022.112745_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10741-007-9009-2","article-title":"Epidemiology of acute heart failure syndromes","volume":"12","author":"Alla","year":"2007","journal-title":"Heart Fail. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2022.112745_bib5","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jacc.2012.01.077","article-title":"Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure","volume":"60","author":"Ronco","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112745_bib6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"g. Acute Dialysis Quality Initiative consensus, Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.biopha.2022.112745_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000448749","article-title":"Cardiorenal syndrome in western countries: epidemiology, diagnosis and management approaches","volume":"2","author":"Ronco","year":"2017","journal-title":"Kidney Dis."},{"issue":"2","key":"10.1016\/j.biopha.2022.112745_bib8","first-page":"75","article-title":"Levosimendan in critical illness: a literature review","volume":"6","author":"Pierrakos","year":"2014","journal-title":"J. Clin. Med. Res."},{"issue":"Suppl C","key":"10.1016\/j.biopha.2022.112745_bib9","doi-asserted-by":"crossref","first-page":"C22","DOI":"10.1093\/eurheartj\/sux002","article-title":"Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan","volume":"19","author":"Fedele","year":"2017","journal-title":"Eur. Heart J. Suppl."},{"issue":"1","key":"10.1016\/j.biopha.2022.112745_bib10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13054-019-2642-z","article-title":"How levosimendan can improve renal function?","volume":"23","author":"Honore","year":"2019","journal-title":"Crit. Care"},{"issue":"6","key":"10.1016\/j.biopha.2022.112745_bib11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10557-013-6485-6","article-title":"Renal effects of levosimendan: a consensus report","volume":"27","author":"Yilmaz","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"3","key":"10.1016\/j.biopha.2022.112745_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/j.ajkd.2015.09.015","article-title":"Levosimendan for prevention of acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials","volume":"67","author":"Zhou","year":"2016","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.biopha.2022.112745_bib13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/jpet.112.193961","article-title":"Levosimendan protection against kidney ischemia\/reperfusion injuries in anesthetized pigs","volume":"342","author":"Grossini","year":"2012","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2022.112745_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108954","article-title":"The therapeutic impact of entresto on protecting against cardiorenal syndrome-associated renal damage in rats on high protein diet","volume":"116","author":"Yang","year":"2019","journal-title":"Biomed. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2022.112745_bib15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"P.-H. Investigators, Committees, Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2022.112745_bib16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jchf.2014.09.001","article-title":"Combined neprilysin and renin-angiotensin system inhibition for the treatment of heart failure","volume":"2","author":"Vardeny","year":"2014","journal-title":"JACC Heart Fail."},{"issue":"9","key":"10.1016\/j.biopha.2022.112745_bib17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cardfail.2016.07.001","volume":"22","author":"Writing Committee","year":"2016","journal-title":"J. Card. Fail"},{"issue":"7","key":"10.1016\/j.biopha.2022.112745_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S2213-8587(18)30142-6","article-title":"Renal effects of sacubitril\/valsartan in patients with diabetes","volume":"6","author":"Stork","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.biopha.2022.112745_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119227","article-title":"Cerebro- and renoprotective activities through platelet-derived biomaterials against cerebrorenal syndrome in rat model","volume":"214","author":"Yip","year":"2019","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.biopha.2022.112745_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jpi.12273","article-title":"Combined melatonin and exendin-4 therapy preserves renal ultrastructural integrity after ischemia-reperfusion injury in the male rat","volume":"59","author":"Yip","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2022.112745_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s12967-014-0357-0","article-title":"Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats","volume":"12","author":"Chua","year":"2014","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.biopha.2022.112745_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092782","article-title":"Combined therapy with SS31 and mitochondria mitigates myocardial ischemia-reperfusion injury in rats","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2022.112745_bib23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/aps.2015.162","article-title":"Administration of antioxidant peptide SS-31 attenuates transverse aortic constriction-induced pulmonary arterial hypertension in mice","volume":"37","author":"Lu","year":"2016","journal-title":"Acta Pharm. Sin."},{"issue":"1","key":"10.1016\/j.biopha.2022.112745_bib24","doi-asserted-by":"crossref","first-page":"13398","DOI":"10.1038\/s41598-019-48792-z","article-title":"Levosimendan pretreatment improves survival of septic rats after partial hepatectomy and suppresses iNOS induction in cytokine-stimulated hepatocytes","volume":"9","author":"Sakaguchi","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2022.112745_bib25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/jpi.12357","article-title":"The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome","volume":"61","author":"Chua","year":"2016","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.biopha.2022.112745_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FJC.0000000000000533","article-title":"Levosimendan in acute and advanced heart failure: an appraisal of the clinical database and evaluation of its therapeutic applications","volume":"71","author":"Altenberger","year":"2018","journal-title":"J. Cardiovasc. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2022.112745_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","article-title":"Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail."},{"issue":"8","key":"10.1016\/j.biopha.2022.112745_bib28","first-page":"2290","article-title":"Entresto therapy effectively protects heart and lung against transverse aortic constriction induced cardiopulmonary syndrome injury in rat","volume":"10","author":"Lu","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biopha.2022.112745_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112551","article-title":"Valsartan- and melatonin-supported adipose-derived mesenchymal stem cells preserve renal function in chronic kidney disease rat through upregulation of prion protein participated in promoting PI3K-Akt-mTOR signaling and cell proliferation","volume":"146","author":"Yang","year":"2022","journal-title":"Biomed. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2022.112745_bib30","first-page":"2548","article-title":"Impact of impaired cardiac function on the progression of chronic kidney disease---role of pharmacomodulation of valsartan","volume":"9","author":"Yang","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biopha.2022.112745_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112244","article-title":"Entresto protected the cardiomyocytes and preserved heart function in cardiorenal syndrome rat fed with high-protein diet through regulating the oxidative stress and Mfn2-mediated mitochondrial functional integrity","volume":"144","author":"Yeh","year":"2021","journal-title":"Biomed. Pharm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222001330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222001330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:30:09Z","timestamp":1781764209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222001330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":31,"alternative-id":["S0753332222001330"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112745","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined levosimendan and Sacubitril\/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112745"}}